科大訊飛(002230.SZ)觸及漲停欲創新高 擬定增募資超20億元 劉慶峯以現金認購
格隆匯1月19日丨科大訊飛(002230.SZ)跳空大漲,盤中一度漲停,報48.37元,股價逼近2017年的歷史最高價49.47元,最新市值突破1000億元。公司昨晚公吿,擬定增募集20億-26億元,本次發行價格為33.58元/股,發行對象為劉慶峯及安徽言知科技有限公司,發行對象將以現金方式認購本次非公開發行的股票。扣除發行費用後,募集資金將全部用於公司補充流動資金,以充實公司資本實力,優化公司資產結構,提高抗風險能力。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.